keyword
https://read.qxmd.com/read/37125243/a-malaysian-consensus-report-on-the-diagnosis-and-treatment-of-helicobacter-pylori-infection
#21
REVIEW
Khean-Lee Goh, Yeong Yeh Lee, Alex Hwong-Ruey Leow, Raja Affendi Raja Ali, Shiaw Hooi Ho, Sanjiv Mahadeva, Rosaida Hj Mohd Said, Raman Muthukaruppan Chettiar, Hoi Poh Tee
Helicobacter pylori is one of the most common chronic bacterial infections in humans and responsible for 90% of duodenal ulcers and 70-90% of gastric ulcers. Despite this, many misconceptions regarding the appropriate diagnostic method and treatment strategies still exist in the Malaysian clinical practice. Under the initiative of the steering committee, an expert panel consisting of nine key opinion leaders in the field of gastroenterology convened to develop a set of consensus statements that are relevant to the Malaysian healthcare practice...
April 2023: JGH Open: An Open Access Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/36968116/focusing-on-helicobacter-pylori-infection-in-the-elderly
#22
REVIEW
Hang Gong, Hui-Mei Xu, De-Kui Zhang
As a confirmed carcinogen, Helicobacter pylori ( H. pylori ) is the main cause of inflammatory diseases of the upper digestive tract and even gastric cancer. There is a high prevalence of H. pylori infection among the elderly population, which may cause adverse clinical outcomes. Particularly noteworthy is that guidelines or expert consensus presently available on H. pylori infection overlook the management of the elderly population as a special group. A brief overview of H. pylori in the elderly is as follows...
2023: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/36907179/helicobacter-pylori-infection-as-predictor-of-treatment-outcomes-of-gastric-cancer-a-systematic-review-and-metanalysis
#23
Chenxiao Gan, Xueping Wu, Yu Shen, Zhongsheng Cao, Jiyong Ji, Wensheng Pan
BACKGROUND: Helicobacter pylori infection is strongly associated with gastric cancer. However, there is currently no consensus on the association between H. pylori and gastric cancer prognosis. METHODS: A systematic search was conducted on studies in PubMed, EMBASE, and Web of Science up to March 10, 2022. The quality of all included studies was assessed using the Newcastle-Ottawa Scale. The hazard ratio (HR) and its 95% confidence interval (95%CI) were extracted to analyze the association between H...
March 10, 2023: Digestive Diseases
https://read.qxmd.com/read/36805362/dual-therapy-for-helicobacter-pylori-infection
#24
JOURNAL ARTICLE
Miao Duan, Jing Liu, Xiuli Zuo
Bismuth-containing quadruple therapy (BQT) has long been recommended for Helicobacter pylori (H. pylori) eradication in China. Meanwhile, in the latest national consensus in China, dual therapy (DT) comprising an acid suppressor and amoxicillin has also been recommended. In recent years, the eradication rate of H. pylori has reached >90% using DT, which has been used not only as a first-line treatment but also as a rescue treatment. Compared with BQT, DT has great potential for H. pylori eradication; however, it has some limitations...
February 14, 2023: Chinese Medical Journal
https://read.qxmd.com/read/36744128/cancer-associated-fibroblast-related-gene-signature-in-helicobacter-pylori-based-subtypes-of-gastric-carcinoma-for-prognosis-and-tumor-microenvironment-estimation-in-silico-analysis
#25
JOURNAL ARTICLE
Ruofan Xu, Le Yang, Zhewen Zhang, Yuxuan Liao, Yao Yu, Dawei Zhou, Jiahao Li, Haoyu Guan, Wei Xiao
INTRODUCTION: Gastric cancer (GC) remains the major constituent of cancer-related deaths and a global public health challenge with a high incidence rate. Helicobacter pylori (HP) plays an essential role in promoting the occurrence and progression of GC. Cancer-associated fibroblasts (CAFs) are regarded as a significant component in the tumor microenvironment (TME), which is related to the metastasis of GC. However, the regulation mechanisms of CAFs in HP-related GC are not elucidated thoroughly...
2023: Frontiers in Medicine
https://read.qxmd.com/read/36567647/treatment-strategies-and-pharmacist-led-medication-management-for-helicobacter-pylori-infection
#26
REVIEW
Yu-Zhen Wang, Jie Chen, Shi-Qin Pei, Chen Wang, Gang Han, Lian-Di Kan, Liu-Cheng Li
Half of the world's population is Helicobacter pylori carrier. Updated guidelines and consensus have been issued across regions with the main aim of reducing social transmission and increasing H. pylori eradication rate. Although alternative therapies including traditional Chinese medicine and probiotics have also been used to improve H. pylori eradication rate in clinical practice, current mainstream treatment is still dependent on triple and quadruple therapies that includes antibacterial agents (e.g...
December 26, 2022: Drug Development Research
https://read.qxmd.com/read/36536553/-consensus-of-chinese-experts-on-clinical-application-of-lactoferrin
#27
JOURNAL ARTICLE
(no author information available yet)
Lactoferrin is a natural protein with various physiological activities, which has the function of regulating immunity, anti-microbial, regulating iron absorption, promoting the proliferation of intestinal cells, and multiple pathophysiological processes. In recent years, lactoferrin has been widely used in infants, pregnant women, and the elderly. In order to more comprehensively understand the clinical application of lactoferrin and establish the method and index system of lactoferrin application in different populations, clinical nutritionists, together with experts from multiple disciplines, used the evidence grading method of GRADE Collaboration Network Ⅱ under the principle of evidence-based medicine to search for clinical evidence and repeatedly discuss...
December 6, 2022: Zhonghua Yu Fang Yi Xue za Zhi [Chinese Journal of Preventive Medicine]
https://read.qxmd.com/read/36530421/the-management-of-helicobacter-pylori-infection-and-prevention-and-control-of-gastric-cancer-in-china
#28
REVIEW
Yi Hu, Yin Zhu, Nong-Hua Lu
Helicobacter pylori ( H. pylori ) infection, a type-1 carcinogen, was closely associated with gastric cancer (GC). Successfully eradicating H. pylori infection could reduce the incidence of GC. China was a country with high incidence of GC and high prevalence of H. pylori infection. Nearly half of worldwide GC new cases and deaths attributed to H. pylori infection occurred in China. H. pylori prevalence varied over time with the improvement of socioeconomic status and sanitary conditions. The knowledge of antibiotic resistance rate in time was important to guide the clinical choice of antibiotics use in the regimens...
2022: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/36506013/current-and-future-perspectives-for-helicobacter-pylori-treatment-and-management-from-antibiotics-to-probiotics
#29
REVIEW
Bing Liang, Yang Yuan, Xiao-Jin Peng, Xin-Lin Liu, Xiao-Kun Hu, Dong-Ming Xing
Helicobacter pylori ( H. pylori ) is a Gram-negative anaerobic bacterium that colonizes the human stomach and is the leading cause of gastric diseases such as chronic gastritis and peptic ulcers, as well as the most definite and controllable risk factor for the development of gastric cancer. Currently, the regimen for H. pylori eradication has changed from triple to quadruple, the course of treatment has been extended, and the type and dose of antibiotics have been adjusted, with limited improvement in efficacy but gradually increasing side effects and repeated treatment failures in an increasing number of patients...
2022: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/36458050/update-on-the-first-line-treatment-of-helicobacter-pylori-infection-in-areas-with-high-and-low-clarithromycin-resistances
#30
REVIEW
Chih-An Shih, Chang-Bih Shie, Ping-I Hsu
Current international consensuses on Helicobacter pylori eradication therapy recommend that only regimens that reliably produce eradication rates of ⩾90% should be used for empirical treatment. The Real-world Practice & Expectation of Asia-Pacific Physicians and Patients in Helicobacter Pylori Eradication Survey also showed that the accepted minimal eradication rate in H. pylori -infected patients was 91%. According to efficacy prediction model, the per-protocol eradication rates of 7-day and 14-day standard triple therapies fall below 90% when clarithromycin resistance rate ⩾5%...
2022: Therapeutic Advances in Gastroenterology
https://read.qxmd.com/read/36204804/practice-guidelines-for-the-management-of-helicobacter-pylori-infection-the-saudi-h-pylori-working-group-recommendations
#31
JOURNAL ARTICLE
Fahad Alsohaibani, Musthafa Peedikayil, Abdulaziz Alshahrani, Ali Somily, Raed Alsulaiman, Nahla Azzam, Majid Almadi
The eradication rates for Helicobacter pylori globally are decreasing with a dramatic increase in the prevalence of antibiotic resistant bacteria all over the world, including Saudi Arabia. There is no current consensus on the management of H. pylori in Saudi Arabia. The Saudi Gastroenterology Association developed these practice guidelines after reviewing the local and regional studies on the management of H. pylori. The aim was to establish recommendations to guide healthcare providers in managing H. pylori in Saudi Arabia...
October 3, 2022: Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association
https://read.qxmd.com/read/36203110/indications-for-upper-gastrointestinal-endoscopy-before-bariatric-surgery-a-multicenter-study
#32
JOURNAL ARTICLE
Hussein Abdallah, Mehdi El Skalli, Hussein Mcheimeche, Biagio Casagranda, Nicolò de Manzini, Silvia Palmisano
BACKGROUND: The role of preoperative upper gastrointestinal endoscopy before bariatric surgery is still debated, and a consensus among the international scientific community is lacking. The aims of this study, conducted in three different geographic areas, were to analyze data regarding the pathological endoscopic findings and report their impact on the decision-making process and surgical management, in terms of delay in surgical operation, modification of the intended bariatric procedure, or contraindication to surgery...
October 6, 2022: Surgical Endoscopy
https://read.qxmd.com/read/36075194/analysis-of-barrett-s-esophagus-and-its-risk-factors-a-cross-sectional-study-of-10-122-subjects-at-a-japanese-health-examination-center
#33
JOURNAL ARTICLE
Dai Kubota, Yu Takahashi, Nobutake Yamamichi, Maki Matsui, Takeshi Shimamoto, Chihiro Minatsuki, Hideki Nakagawa, Satoru Mizutani, Yosuke Tsuji, Yoshiki Sakaguchi, Naoki Tamura, Seiichi Yakabi, Daisuke Ohki, Hiroya Mizutani, Keiko Niimi, Ryoichi Wada, Mitsuhiro Fujishiro
INTRODUCTION: Helicobacter pylori eradication is expected to significantly change the prevalence of Barrett's esophagus (BE). However, few reports on this relationship exist. We analyzed the risk factors of BE using the current consensus on length of BE considering H. pylori infection status. METHODS: We analyzed 10,122 individuals (5,962 men; mean age = 52.9 ± 9.9 years) who had undergone esophagogastroduodenoscopy as part of a medical checkup. Correlations among factors including H...
2022: Digestion
https://read.qxmd.com/read/35979311/current-guidelines-for-helicobacter-pylori-treatment-in-east-asia-2022-differences-among-china-japan-and-south-korea
#34
REVIEW
Jun-Hyung Cho, So-Young Jin
Helicobacter pylori ( H. pylori ) infection is highly prevalent in East Asia. The overall seroprevalence rate of H. pylori infection is 44.2% in China, 37.6%-43.2% in Japan, and 51.0% in South Korea. H. pylori can cause peptic ulcer disease and gastric cancer. East Asian countries have high rates of gastric cancer (age-standardized incidence rate: 20-30 per 100000). The Kyoto global consensus report emphasized that H. pylori gastritis should be considered the main cause for the development of gastric cancer...
July 6, 2022: World Journal of Clinical Cases
https://read.qxmd.com/read/35944925/management-of-helicobacter-pylori-infection-the-maastricht-vi-florence-consensus-report
#35
JOURNAL ARTICLE
Peter Malfertheiner, Francis Megraud, Theodore Rokkas, Javier P Gisbert, Jyh-Ming Liou, Christian Schulz, Antonio Gasbarrini, Richard H Hunt, Marcis Leja, Colm O'Morain, Massimo Rugge, Sebastian Suerbaum, Herbert Tilg, Kentaro Sugano, Emad M El-Omar
Helicobacter pylori Infection is formally recognised as an infectious disease, an entity that is now included in the International Classification of Diseases 11th Revision. This in principle leads to the recommendation that all infected patients should receive treatment. In the context of the wide clinical spectrum associated with Helicobacter pylori gastritis, specific issues persist and require regular updates for optimised management.The identification of distinct clinical scenarios, proper testing and adoption of effective strategies for prevention of gastric cancer and other complications are addressed...
August 8, 2022: Gut
https://read.qxmd.com/read/35816511/low-compliance-to-post-screening-recommendations-in-a-family-based-helicobacter-pylori-screening-and-treatment-program-a-prospective-cohort-study
#36
JOURNAL ARTICLE
Qingzhou Kong, Yueyue Li, Ruili Li, Zhiyuan Li, Xueting Zheng, Zhi Wang, Kun Song, Xia Zhang, Jing Liu, Zhongxue Han, Miao Duan, Yuming Ding, Wenlin Zhang, Minjuan Lin, Juan Wang, Meng Wan, Boshen Lin, Shaotong Wang, Xiuli Zuo, Yanqing Li
BACKGROUND: Intra-family transmission is an important Helicobacter pylori (H. pylori) infection route. Family-based screening and treatment of H. pylori is a promising strategy. However, limited data are available on patient compliance with post-screening recommendations for such a strategy. MATERIALS AND METHODS: A prospective cohort study of families from six regions in Shandong, China, from July 2021 to February 2022 was conducted. Demographic characteristics, prior testing, and treatment for H...
July 11, 2022: Helicobacter
https://read.qxmd.com/read/35740684/management-of-extranodal-marginal-zone-lymphoma-present-and-upcoming-perspectives
#37
REVIEW
Dominic Kaddu-Mulindwa, Lorenz Thurner, Konstantinos Christofyllakis, Moritz Bewarder, Igor Age Kos
Extranodal marginal zone lymphoma (EMZL) encompasses a subgroup of non-Hodgkin lymphomas that often present with localized involvement and may manifest in a diversity of organs and tissues. EMZL pathogenesis is in some cases linked to chronic inflammation/infection, which may impose additional diagnostic and clinical challenges. The most studied and established connection is the presence of Helicobacter pylori in gastric EMZL. Due to its heterogeneity of presentation and intricate pathological features, treatment can be complex, and staging systems are decisive for the choice of therapy...
June 19, 2022: Cancers
https://read.qxmd.com/read/35725291/kyoto-international-consensus-report-on-anatomy-pathophysiology-and-clinical-significance-of-the-gastro-oesophageal-junction
#38
JOURNAL ARTICLE
Kentaro Sugano, Stuart Jon Spechler, Emad M El-Omar, Kenneth E L McColl, Kaiyo Takubo, Takuji Gotoda, Mitsuhiro Fujishiro, Katsunori Iijima, Haruhiro Inoue, Takashi Kawai, Yoshikazu Kinoshita, Hiroto Miwa, Ken-Ichi Mukaisho, Kazunari Murakami, Yasuyuki Seto, Hisao Tajiri, Shobna Bhatia, Myung-Gyu Choi, Rebecca C Fitzgerald, Kwong Ming Fock, Khean-Lee Goh, Khek Yu Ho, Varocha Mahachai, Maria O'Donovan, Robert Odze, Richard Peek, Massimo Rugge, Prateek Sharma, Jose D Sollano, Michael Vieth, Justin Wu, Ming-Shiang Wu, Duowu Zou, Michio Kaminishi, Peter Malfertheiner
OBJECTIVE: An international meeting was organised to develop consensus on (1) the landmarks to define the gastro-oesophageal junction (GOJ), (2) the occurrence and pathophysiological significance of the cardiac gland, (3) the definition of the gastro-oesophageal junctional zone (GOJZ) and (4) the causes of inflammation, metaplasia and neoplasia occurring in the GOJZ. DESIGN: Clinical questions relevant to the afore-mentioned major issues were drafted for which expert panels formulated relevant statements and textural explanations...
August 2022: Gut
https://read.qxmd.com/read/35704259/patient-selection-in-one-anastomosis-mini-gastric-bypass-an-expert-modified-delphi-consensus
#39
JOURNAL ARTICLE
Mohammad Kermansaravi, Chetan Parmar, Sonja Chiappetta, Shahab Shahabi, Alaa Abbass, Syed Imran Abbas, Mohamed Abouzeid, Luciano Antozzi, Syed Tanseer Asghar, Ahmad Bashir, Mohit Bhandari, Helmuth Billy, Daniel Caina, Francisco J Campos, Miguel-A Carbajo, Jean Marc Chevallier, Amir Hossein Davarpanah Jazi, Amador Garcia Ruiz de Gordejuela, Ashraf Haddad, Mohamad Hayssam ElFawal, Jacques Himpens, Aatif Inam, Radwan Kassir, Kazunori Kasama, Amir Khan, Lilian Kow, Kuldeepak Singh Kular, Muffazal Lakdawala, Laurent Abram Layani, Wei-Jei Lee, Enrique Luque-de-León, Ken Loi, Kamal Mahawar, Tarek Mahdy, Mario Musella, Abdelrahman Nimeri, Juan Carlos Olivares González, Abdolreza Pazouki, Tigran Poghosyan, Gerhard Prager, Arun Prasad, Almino C Ramos, Karl Rheinwalt, Rui Ribeiro, Elena Ruiz-Úcar, Robert Rutledge, Asim Shabbir, Scott Shikora, Rishi Singhal, Osama Taha, Mohammad Talebpour, Jose Sergio Verboonen, Cunchuan Wang, Rudolf Weiner, Wah Yang, Ramon Vilallonga, Maurizio De Luca
PURPOSE: One anastomosis/mini gastric bypass (OAGB/MGB) is up to date the third most performed obesity and metabolic procedure worldwide, which recently has been endorsed by ASMBS. The main criticisms are the risk of bile reflux, esophageal cancer, and malnutrition. Although IFSO has recognized this procedure, guidance is needed regarding selection criteria. To give clinicians a daily support in performing the right patient selection in OAGB/MGB, the aim of this paper is to generate clinical guidelines based on an expert modified Delphi consensus...
August 2022: Obesity Surgery
https://read.qxmd.com/read/35692014/-personalized-therapy-for-helicobacter-pylori-on-initial-treatment-the-initial-treatment-is-the-decisive-battle
#40
JOURNAL ARTICLE
H J Gao, L J Zhong, X Y Yan, W X Zhang, Weixiang Shen
As widespread eradication treatment continues, the rate of ( Helicobacter pylori, H. pylori ) antibiotic resistance is increasing. Together with host CYP2C19 gene polymorphisms, H. pylori coccoid transformation, patient compliance, irregular treatment regimens or empirical repeated eradication therapy by physician, H. pylori eradication rates have gradually decreased. Personalized treatment is an effective measure to achieve successful eradication of H. pylori in the initial treatment. With the first approval of molecular diagnostic kit for H...
June 14, 2022: Zhonghua Yi Xue za Zhi [Chinese medical journal]
keyword
keyword
163560
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.